Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Bimatoprost Topical Solution in the Treatment of Androgenetic Alopecia in Men

NCT02676310 is registered in ClinicalTrials.gov with Allergan as lead sponsor.

NCT NCT02676310
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02676310 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dose Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Bimatoprost Topical Solution in the Treatment of Androgenetic Alopecia in Men
Lead sponsor
Allergan
Phase
Phase 1
Overall status
Terminated
Start date
March 31, 2016
Completion date
March 31, 2017
Enrollment
53 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

alopecia, alopecia, androgenetic, baldness